These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31763671)

  • 1. Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    Boniface K; Byars SG; Cowley D; Kirkwood CD; Bines JE
    J Infect Dis; 2020 Mar; 221(7):1070-1078. PubMed ID: 31763671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
    Donato CM; Handley A; Byars SG; Bogdanovic-Sakran N; Lyons EA; Watts E; Ong DS; Pavlic D; At Thobari J; Satria CD; Nirwati H; Soenarto Y; Bines JE
    J Infect Dis; 2024 Apr; 229(4):1010-1018. PubMed ID: 37592804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
    Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
    Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of elevated rotavirus-specific antibody titers with HBGA secretor status in Swedish individuals: The FUT2 gene as a putative susceptibility determinant for infection.
    Günaydın G; Nordgren J; Sharma S; Hammarström L
    Virus Res; 2016 Jan; 211():64-8. PubMed ID: 26454189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    Armah GE; Cortese MM; Dennis FE; Yu Y; Morrow AL; McNeal MM; Lewis KDC; Awuni DA; Armachie J; Parashar UD
    J Infect Dis; 2019 Feb; 219(5):746-749. PubMed ID: 30357332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
    Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM; Ali A
    J Infect Dis; 2017 Mar; 215(5):786-789. PubMed ID: 28329092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.
    Pollock L; Bennett A; Jere KC; Dube Q; Mandolo J; Bar-Zeev N; Heyderman RS; Cunliffe NA; Iturriza-Gomara M
    Clin Infect Dis; 2019 Sep; 69(8):1313-1319. PubMed ID: 30561537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Pavlic D; Bogdanovic-Sakran N; Boniface K; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2018; 14(8):2082-2087. PubMed ID: 29688121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
    Witte D; Handley A; Jere KC; Bogandovic-Sakran N; Mpakiza A; Turner A; Pavlic D; Boniface K; Mandolo J; Ong DS; Bonnici R; Justice F; Bar-Zeev N; Iturriza-Gomara M; Ackland J; Donato CM; Cowley D; Barnes G; Cunliffe NA; Bines JE
    Lancet Infect Dis; 2022 May; 22(5):668-678. PubMed ID: 35065683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
    Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Loureiro Tonini MA; Pires Gonçalves Barreira DM; Bueno de Freitas Santolin L; Bondi Volpini LP; Gagliardi Leite JP; Le Moullac-Vaidye B; Le Pendu J; Cruz Spano L
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination.
    Middleton BF; Danchin M; Cunliffe NA; Jones MA; Boniface K; Kirkwood CD; Gallagher S; Kirkham LA; Granland C; McNeal M; Donato C; Bogdanovic-Sakran N; Handley A; Bines JE; Snelling TL
    Vaccine; 2023 Jun; 41(24):3579-3583. PubMed ID: 37179162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.
    Sharma S; Nordgren J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
    Bines JE; At Thobari J; Satria CD; Handley A; Watts E; Cowley D; Nirwati H; Ackland J; Standish J; Justice F; Byars G; Lee KJ; Barnes GL; Bachtiar NS; Viska Icanervilia A; Boniface K; Bogdanovic-Sakran N; Pavlic D; Bishop RF; Kirkwood CD; Buttery JP; Soenarto Y
    N Engl J Med; 2018 Feb; 378(8):719-730. PubMed ID: 29466164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.
    Danchin MH; Bines JE; Watts E; Cowley D; Pavlic D; Lee KJ; Huque H; Kirkwood C; Nirwati H; At Thobari J; Dewi Satria C; Soenarto Y; Oktaria V
    Vaccine; 2020 Apr; 38(16):3235-3242. PubMed ID: 32160948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
    J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Rotavirus P[6] Infection in Korean Neonates and Histo-Blood Group Antigen: a Single-Center Study.
    Lee SK; Oh SJ; Choi S; Choi SH; Shin SH; Lee EJ; Cho EJ; Hyun J; Kim HS
    Ann Lab Med; 2021 Mar; 41(2):181-189. PubMed ID: 33063679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.